Octamethylcyclotetra-siloxane (D4); Manufacturer Request for Risk Evaluation Under the Toxic Substances Control Act (TSCA); Notice of Availability and Request for Comments, 36586-36588 [2020-13037]
Download as PDF
<![CDATA[
36586
Federal Register / Vol. 85, No. 117 / Wednesday, June 17, 2020 / Notices
III. Summary of Public Comments
Received and Agency Response to
Comments
During the public comment period
provided, EPA received five public
comments; four of them are anonymous,
in response to the April 17, 2020
Federal Register notice announcing the
Agency’s receipt of the requests for
voluntary cancellations and
amendments to terminate uses of
products listed in Tables 1, 1A, 1B and
2 of Unit II. The Agency does not
believe that the comments submitted
during the comment period merit
further review or a denial of the requests
for voluntary cancellation and use
termination.
IV. Cancellation Order
Pursuant to FIFRA section 6(f) (7
U.S.C. 136d(f)(1)), EPA hereby approves
the requested cancellations and
amendments to terminate uses of the
registrations identified in Tables 1, 1A,
1B, and 2 of Unit II. Accordingly, the
Agency hereby orders that the product
registrations identified in Tables 1, 1A,
1B, and 2 of Unit II are canceled and
amended to terminate the affected uses.
The effective date of the cancellations
and amendments listed in Table 1 and
Table 2 that are subject of this notice is
June 17, 2020. The effective date of the
cancellation listed in Table 1A that is
subject of this notice is December 31,
2020. The effective date of the
cancellations listed in Table 1B that are
subject of this notice is December 31,
2019. Any distribution, sale, or use of
existing stocks of the products
identified in Tables 1, 1A, 1B, and 2 of
Unit II in a manner inconsistent with
any of the provisions for disposition of
existing stocks set forth in Unit VI will
be a violation of FIFRA.
khammond on DSKJM1Z7X2PROD with NOTICES
V. What is the Agency’s authority for
taking this action?
Section 6(f)(1) of FIFRA (7 U.S.C.
136d(f)(1)) provides that a registrant of
a pesticide product may at any time
request that any of its pesticide
registrations be canceled or amended to
terminate one or more uses. FIFRA
further provides that, before acting on
the request, EPA must publish a notice
of receipt of any such request in the
Federal Register. Thereafter, following
the public comment period, the EPA
Administrator may approve such a
request. The notice of receipt for this
action was published for comment in
the Federal Register of Apr 17, 2020 (85
FR 21428) (FRL–10007–07). The
comment period closed on May 18,
2020.
VerDate Sep<11>2014
16:44 Jun 16, 2020
Jkt 250001
VI. Provisions for Disposition of
Existing Stocks
Existing stocks are those stocks of
registered pesticide products which are
currently in the United States and
which were packaged, labeled, and
released for shipment prior to the
effective date of the action. The existing
stocks provision for the products subject
to this order is as follows.
A. For Product 10324–66
For product 10324–66, listed in Table
1 of Unit II, the registrant has requested
18-months to sell existing stocks. The
registrant will be permitted to sell and
distribute existing stocks of the product
for 18-months after the effective date of
the cancellation, which will be the date
of publication of the cancellation order
in the Federal Register. Thereafter, the
registrant will be prohibited from selling
or distributing the product, except for
export consistent with FIFRA section 17
(7 U.S.C. 136o) or for proper disposal.
B. For Product 432–893
For product 432–893, listed in Table
1A of Unit II, the registrant has
requested the cancellation date to be
December 31, 2020; therefore, the
registrant will be permitted to sell and
distribute existing stocks of the
voluntarily canceled product for 1 year
after the effective date of the
cancellation, which will be until
December 31, 2021. Thereafter, the
registrant will be prohibited from selling
or distributing the product, except for
export consistent with FIFRA section 17
(7 U.S.C. 136o) or for proper disposal.
C. For Products CA–040026, CA–
080009, CA–080010, CA–080011 & CA–
080012
For products CA–040026, CA–080009,
CA–080010, CA–080011 & CA–080012,
listed in Table 1B of Unit II, the
registrant has requested the cancellation
date to be December 31, 2019; therefore,
the registrant will be permitted to sell
and distribute existing stocks of
voluntarily canceled products for 1 year
after the effective date of the
cancellation, which will be until
December 31, 2020. Thereafter, the
registrant will be prohibited from selling
or distributing these products, except
for export consistent with FIFRA section
17 (7 U.S.C. 136o) or for proper
disposal.
For all other voluntary cancellations,
identified in Table 1 of Unit II, the
registrants may continue to sell and
distribute existing stocks of the products
listed in Table 1 until June 17, 2021,
which is 1 year after publication of this
cancellation order in the Federal
Register. Thereafter, the registrants are
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
prohibited from selling or distributing
the products listed in Table 1 of Unit II,
except for export in accordance with
FIFRA section 17 (7 U.S.C. 136o) or for
proper disposal.
Now that EPA has approved product
labels reflecting the requested
amendments to terminate uses,
registrants are permitted to sell or
distribute products listed in Table 2 of
Unit II under the previously approved
labeling until December 17, 2021, a
period of 18 months after publication of
the cancellation order in this Federal
Register, unless other restrictions have
been imposed. Thereafter, registrants
will be prohibited from selling or
distributing the products whose labels
include the terminated use identified in
Table 2 of Unit II, except for export
consistent with FIFRA section 17 or for
proper disposal.
Persons other than the registrant may
sell, distribute, or use existing stocks of
canceled products and products whose
labels include the terminated uses until
supplies are exhausted, provided that
such sale, distribution, or use is
consistent with the terms of the
previously approved labeling on, or that
accompanied, the canceled products
and terminated uses.
Authority: 7 U.S.C. 136 et seq.
Dated: June 4, 2020.
Delores Barber,
Director, Information Technology and
Resources Management Division, Office of
Pesticide Programs.
[FR Doc. 2020–13047 Filed 6–16–20; 8:45 am]
BILLING CODE 6560–50–P
ENVIRONMENTAL PROTECTION
AGENCY
[EPA–HQ–OPPT–2018–0443; FRL–10010–
49]
Octamethylcyclotetra-siloxane (D4);
Manufacturer Request for Risk
Evaluation Under the Toxic
Substances Control Act (TSCA); Notice
of Availability and Request for
Comments
Environmental Protection
Agency (EPA).
ACTION: Notice.
AGENCY:
EPA is announcing the
availability of and soliciting public
comment on a manufacturer request for
a risk evaluation of
octamethylcyclotetra-siloxane (D4)
under the Toxic Substances Control Act
(TSCA). The request was made by Dow
Silicones Corporation, Elkem Silicones
USA Corporation, Evonik Corporation,
Momentive Performance Materials,
SUMMARY:
E:\FR\FM\17JNN1.SGM
17JNN1
khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 85, No. 117 / Wednesday, June 17, 2020 / Notices
Shin-Etsu Silicones of America, Inc.;
and Wacker Chemical Corporation
through the American Chemistry
Council’s Silicones Environmental,
Health, and Safety Center (SEHSC). EPA
conducts risk evaluations to determine
whether a chemical substance presents
an unreasonable risk of injury to health
or the environment without
consideration of costs or other non-risk
factors, including an unreasonable risk
to potentially exposed or susceptible
subpopulations, under the conditions of
use. In the docket associated with this
request is the manufacturer request for
an EPA-conducted risk evaluation and
possible additional conditions of use
EPA has identified for inclusion within
the scope of a risk evaluation of D4.
After considering comments received in
response to this solicitation, EPA will
determine whether to grant or deny the
manufacturer request. All TSCA risk
evaluations, whether EPA-initiated or
manufacturer-requested, will be
conducted in the same manner.
DATES: Comments must be received on
or before August 3, 2020.
ADDRESSES: Submit your comments,
identified by docket identification (ID)
number EPA–HQ–OPPT–2018–0443, by
one of the following methods:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the online
instructions for submitting comments.
Do not submit electronically any
information you consider to be
Confidential Business Information (CBI)
or other information whose disclosure is
restricted by statute.
• Mail: Document Control Office
(7407M), Office of Pollution Prevention
and Toxics (OPPT), Environmental
Protection Agency, 1200 Pennsylvania
Ave. NW, Washington, DC 20460–0001.
• Hand Delivery: To make special
arrangements for hand delivery or
delivery of boxed information, please
follow the instructions at https://
www.epa.gov/dockets/contacts.html.
Please note that due to the public
health emergency the EPA Docket
Center (EPA/DC) and Reading Room
were closed to public visitors on March
31, 2020. Our EPA/DC staff will
continue to provide customer service
via email, phone, and webform. For
further information on EPA/DC services,
docket contact information and the
current status of the EPA/DC and
Reading Room, please visit https://
www.epa.gov/dockets.
FOR FURTHER INFORMATION CONTACT:
For technical information contact:
Bethany Masten, National Program
Chemicals Division, Office of Pollution
Prevention and Toxics, Environmental
Protection Agency, Mail Code 7404T,
VerDate Sep<11>2014
16:44 Jun 16, 2020
Jkt 250001
1200 Pennsylvania Ave. NW,
Washington, DC 20460–0001; telephone
number: (202) 564–8803; email address:
masten.bethany@epa.gov.
For general information contact: The
TSCA-Hotline, ABVI-Goodwill, 422
South Clinton Ave., Rochester, NY
14620; telephone number: (202) 554–
1404; email address: TSCA-Hotline@
epa.gov.
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this apply to me?
This notice is directed to the public
in general and may be of interest to
persons who currently or may
manufacture (including import),
process, distribute, use, and/or dispose
of D4. Since other entities may also be
interested in these risk evaluations, EPA
has not attempted to describe all the
specific entities that may be affected by
this action.
B. What is EPA’s authority for taking
this action?
TSCA section 6(b) requires that EPA
conduct risk evaluations on existing
chemical substances and identifies the
minimum components EPA must
include in all chemical substance risk
evaluations. 15 U.S.C. 2605(b). The risk
evaluation must not consider costs or
other non-risk factors. 15 U.S.C.
2605(b)(4)(F)(iii). The specific risk
evaluation process is set out in 40 CFR
part 702 and summarized on EPA’s
website at https://www.epa.gov/
assessing-and-managing-chemicalsunder-tsca/risk-evaluations-existingchemicals-under-tsca.
TSCA section 6(b) also allows
manufacturers of a chemical substance
to request an EPA-conducted risk
evaluation on the chemical substance.
TSCA required EPA to develop the form
and manner under which these requests
must be made, and the criteria for which
EPA will determine whether to grant a
request. These requirements and criteria
are set out in 40 CFR 702.37.
Under 40 CFR 702.37(e)(3), EPA is
required to assess whether the
circumstances identified in a
manufacturer request for a risk
evaluation constitute conditions of use
(as defined under TSCA section (3)(4)
and implementing regulations (40 CFR
702.33), and whether those conditions
of use warrant inclusion within the
scope of a risk evaluation for the
chemical substance. EPA will also
assess what, if any, additional
conditions of use warrant inclusion
within the scope of a risk evaluation for
the chemical substance. EPA will
conduct these assessments based on the
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
36587
same considerations applied in the same
manner as it would for a risk evaluation
in the EPA-initiated risk evaluation
process.
No later than 60 business days after
receiving a manufacturer request for risk
evaluation that EPA has determined to
be facially complete (meeting the
criteria set forth in 40 CFR 702.37(e)(1)),
EPA is required to submit for
publication the receipt of the request in
the Federal Register, open a public
docket for the request (which must
contain the manufacturer request and
EPA’s possible additional conditions of
use), and provide no less than 45
calendar days for public comment. This
notice identifies the docket containing
the manufacturer request, EPA’s
possible additional conditions of use,
and the basis for including those
possible additional conditions of use.
During the public comment period, the
public may submit comments and
information relevant to the requested
risk evaluation, as well as the additional
possible conditions of use EPA is
including in the docket.
After the comment period closes, the
Agency has up to 60 days to either grant
or deny the request to conduct a risk
evaluation under 40 CFR 702.37(e)(6).
EPA will review the request along with
any additional information received
during the comment period, and grant
the request if it determines the request
meets all of the following requirements
listed under 40 CFR 702.37(e)(6)(ii):
• The circumstances identified in the
request constitute conditions of use that
warrant inclusion in a risk evaluation
for the chemical substance;
• EPA has all the information needed
to conduct such risk evaluation on the
conditions of use that were the subject
of the request; and
• All other criteria and requirements
of 40 CFR 702.37 have been met.
C. What action is EPA taking?
EPA is announcing the availability of
and soliciting public comment on a
manufacturer request for a risk
evaluation of D4 under TSCA section
6(b) that is described in detail in Unit
II. Also available in the docket
associated with this request are the
manufacturer request and possible
additional conditions of use EPA
identified for inclusion in a risk
evaluation of D4. This notice satisfies 40
CFR 702.37(e)(4).
D. What should I consider as I prepare
my comments for EPA?
1. Submitting CBI. Do not submit this
information to EPA through
regulations.gov or email. Clearly mark
the part or all of the information that
E:\FR\FM\17JNN1.SGM
17JNN1
36588
Federal Register / Vol. 85, No. 117 / Wednesday, June 17, 2020 / Notices
you claim to be CBI. For CBI
information in a disk or CD–ROM that
you mail to EPA, mark the outside of the
disk or CD–ROM as CBI and then
identify electronically within the disk or
CD–ROM the specific information that
is claimed CBI. In addition to one
complete version of the comment that
includes information claimed as CBI, a
copy of the comment that does not
contain the information claimed as CBI
must be submitted for inclusion in the
public docket. Information so marked
will not be disclosed except in
accordance with procedures set forth in
40 CFR part 2.
2. Tips for preparing your comments.
When preparing and submitting your
comments, see the commenting tips at
https://www.epa.gov/dockets/
comments.html.
II. Summary of This Manufacturer
Request
On March 19, 2020, EPA received a
complete manufacturer request for a
TSCA risk evaluation of D4 that was
made by Dow Silicones Corporation,
Elkem Silicones USA Corporation,
Evonik Corporation, Momentive
Performance Materials, Shin-Etsu
Silicones of American, Inc.; and Wacker
Chemical Corporation through the
American Chemistry Council’s Silicones
Environmental, Health, and Safety
Center (SEHSC). After determining the
request was facially complete (i.e., EPA
determined that the request appeared to
be consistent with the requirements in
40 CFR 702.37(b) through (d), such as
including all the necessary information
in those paragraphs), EPA notified the
public of the receipt of the request on
April 8, 2020 via a listserv
announcement to stakeholders.
khammond on DSKJM1Z7X2PROD with NOTICES
A. What is octamethylcyclotetrasiloxane (D4)?
D4 is used to make other silicone
chemicals and as an ingredient in some
personal care products. This substance
is listed on the TSCA Inventory with CA
Index Name ‘‘Cyclotetrasiloxane,
2,2,4,4,6,6,8,8-octamethyl-’’ and the
associated Chemical Abstracts Service
Registry Number (CASRN) 556–67–2.
B. What are the conditions of use?
The manufacturer request for a risk
evaluation of D4 identifying conditions
of use of interest to the manufacturer is
included in docket EPA–HQ–OPPT–
2018–0443. Subject to further analysis
and public comment, EPA anticipates
including activities identified in the
request as conditions of use in the risk
evaluation of D4.
EPA has identified additional
conditions of use pursuant to 40 CFR
VerDate Sep<11>2014
16:44 Jun 16, 2020
Jkt 250001
702.37(e)(3), which are also included in
docket EPA–HQ–OPPT–2018–0443.
III. Request for Comment
The docket associated with this
request contains the manufacturer
request (excluding information claimed
as CBI), EPA’s possible additional
conditions of use as described 40 CFR
702.37(e)(3), and the basis for these
possible additions. During the comment
period, the public may submit
comments and information relevant to
the requested risk evaluation; in
particular, commenters are encouraged
to identify any information not included
in the request that the commenters
believe would be needed to conduct a
risk evaluation, and to provide any
other information relevant to EPA’s
possible additional conditions of use,
such as information on other conditions
of use of the chemical substance than
those included in the request or in
EPA’s possible additional conditions of
use. 40 CFR 702.37(e)(4). In addition, at
any time prior to the end of the
comment period, the requesting
manufacturer(s) may supplement the
original request with any new
information it receives. 40 CFR
702.37(e)(5).
Authority: 15 U.S.C. 2601 et seq.
Andrew Wheeler,
Administrator.
[FR Doc. 2020–13037 Filed 6–16–20; 8:45 am]
BILLING CODE 6560–50–P
FEDERAL COMMUNICATIONS
COMMISSION
[OMB 3060–0463; FRS 16846]
Information Collection Being Reviewed
by the Federal Communications
Commission
Federal Communications
Commission.
ACTION: Notice and request for
comments.
AGENCY:
As part of its continuing effort
to reduce paperwork burdens, and as
required by the Paperwork Reduction
Act (PRA), the Federal Communications
Commission (FCC or Commission)
invites the general public and other
Federal agencies to take this
opportunity to comment on the
following information collections.
Comments are requested concerning:
Whether the proposed collection of
information is necessary for the proper
performance of the functions of the
Commission, including whether the
information shall have practical utility;
the accuracy of the Commission’s
SUMMARY:
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
burden estimate; ways to enhance the
quality, utility, and clarity of the
information collected; ways to minimize
the burden of the collection of
information on the respondents,
including the use of automated
collection techniques or other forms of
information technology; and ways to
further reduce the information
collection burden on small business
concerns with fewer than 25 employees.
DATES: Written comments should be
submitted on or before August 17, 2020.
If you anticipate that you will be
submitting comments, but find it
difficult to do so within the period of
time allowed by this notice, you should
advise the contacts below as soon as
possible.
ADDRESSES: Direct all PRA comments to
Cathy Williams, FCC, via email PRA@
fcc.gov and to Cathy.Williams@fcc.gov.
FOR FURTHER INFORMATION CONTACT: For
additional information about the
information collection, contact Cathy
Williams at (202) 418–2918.
SUPPLEMENTARY INFORMATION: The FCC
may not conduct or sponsor a collection
of information unless it displays a
currently valid Office of Management
and Budget (OMB) control number. No
person shall be subject to any penalty
for failing to comply with a collection
of information subject to the PRA that
does not display a valid OMB control
number.
As part of its continuing effort to
reduce paperwork burdens, and as
required by the PRA of 1995 (44 U.S.C.
3501–3520), the FCC invites the general
public and other Federal agencies to
take this opportunity to comment on the
following information collections.
Comments are requested concerning:
Whether the proposed collection of
information is necessary for the proper
performance of the functions of the
Commission, including whether the
information shall have practical utility;
the accuracy of the Commission’s
burden estimate; ways to enhance the
quality, utility, and clarity of the
information collected; ways to minimize
the burden of the collection of
information on the respondents,
including the use of automated
collection techniques or other forms of
information technology; and ways to
further reduce the information
collection burden on small business
concerns with fewer than 25 employees.
OMB Control Number: 3060–0463.
Title: Telecommunications Relay
Services and Speech-to-Speech Services
for Individuals with Hearing and
Speech Disabilities; Structure and
Practices of the Video Relay Service
Program; Misuse of internet Protocol
E:\FR\FM\17JNN1.SGM
17JNN1
]]>Agencies
[Federal Register Volume 85, Number 117 (Wednesday, June 17, 2020)]
[Notices]
[Pages 36586-36588]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-13037]
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
[EPA-HQ-OPPT-2018-0443; FRL-10010-49]
Octamethylcyclotetra-siloxane (D4); Manufacturer Request for Risk
Evaluation Under the Toxic Substances Control Act (TSCA); Notice of
Availability and Request for Comments
AGENCY: Environmental Protection Agency (EPA).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: EPA is announcing the availability of and soliciting public
comment on a manufacturer request for a risk evaluation of
octamethylcyclotetra-siloxane (D4) under the Toxic Substances Control
Act (TSCA). The request was made by Dow Silicones Corporation, Elkem
Silicones USA Corporation, Evonik Corporation, Momentive Performance
Materials,
[[Page 36587]]
Shin-Etsu Silicones of America, Inc.; and Wacker Chemical Corporation
through the American Chemistry Council's Silicones Environmental,
Health, and Safety Center (SEHSC). EPA conducts risk evaluations to
determine whether a chemical substance presents an unreasonable risk of
injury to health or the environment without consideration of costs or
other non-risk factors, including an unreasonable risk to potentially
exposed or susceptible subpopulations, under the conditions of use. In
the docket associated with this request is the manufacturer request for
an EPA-conducted risk evaluation and possible additional conditions of
use EPA has identified for inclusion within the scope of a risk
evaluation of D4. After considering comments received in response to
this solicitation, EPA will determine whether to grant or deny the
manufacturer request. All TSCA risk evaluations, whether EPA-initiated
or manufacturer-requested, will be conducted in the same manner.
DATES: Comments must be received on or before August 3, 2020.
ADDRESSES: Submit your comments, identified by docket identification
(ID) number EPA-HQ-OPPT-2018-0443, by one of the following methods:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the online instructions for submitting comments. Do not submit
electronically any information you consider to be Confidential Business
Information (CBI) or other information whose disclosure is restricted
by statute.
Mail: Document Control Office (7407M), Office of Pollution
Prevention and Toxics (OPPT), Environmental Protection Agency, 1200
Pennsylvania Ave. NW, Washington, DC 20460-0001.
Hand Delivery: To make special arrangements for hand
delivery or delivery of boxed information, please follow the
instructions at https://www.epa.gov/dockets/contacts.html.
Please note that due to the public health emergency the EPA Docket
Center (EPA/DC) and Reading Room were closed to public visitors on
March 31, 2020. Our EPA/DC staff will continue to provide customer
service via email, phone, and webform. For further information on EPA/
DC services, docket contact information and the current status of the
EPA/DC and Reading Room, please visit https://www.epa.gov/dockets.
FOR FURTHER INFORMATION CONTACT:
For technical information contact: Bethany Masten, National Program
Chemicals Division, Office of Pollution Prevention and Toxics,
Environmental Protection Agency, Mail Code 7404T, 1200 Pennsylvania
Ave. NW, Washington, DC 20460-0001; telephone number: (202) 564-8803;
email address: [email protected].
For general information contact: The TSCA-Hotline, ABVI-Goodwill,
422 South Clinton Ave., Rochester, NY 14620; telephone number: (202)
554-1404; email address: [email protected].
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this apply to me?
This notice is directed to the public in general and may be of
interest to persons who currently or may manufacture (including
import), process, distribute, use, and/or dispose of D4. Since other
entities may also be interested in these risk evaluations, EPA has not
attempted to describe all the specific entities that may be affected by
this action.
B. What is EPA's authority for taking this action?
TSCA section 6(b) requires that EPA conduct risk evaluations on
existing chemical substances and identifies the minimum components EPA
must include in all chemical substance risk evaluations. 15 U.S.C.
2605(b). The risk evaluation must not consider costs or other non-risk
factors. 15 U.S.C. 2605(b)(4)(F)(iii). The specific risk evaluation
process is set out in 40 CFR part 702 and summarized on EPA's website
at https://www.epa.gov/assessing-and-managing-chemicals-under-tsca/risk-evaluations-existing-chemicals-under-tsca.
TSCA section 6(b) also allows manufacturers of a chemical substance
to request an EPA-conducted risk evaluation on the chemical substance.
TSCA required EPA to develop the form and manner under which these
requests must be made, and the criteria for which EPA will determine
whether to grant a request. These requirements and criteria are set out
in 40 CFR 702.37.
Under 40 CFR 702.37(e)(3), EPA is required to assess whether the
circumstances identified in a manufacturer request for a risk
evaluation constitute conditions of use (as defined under TSCA section
(3)(4) and implementing regulations (40 CFR 702.33), and whether those
conditions of use warrant inclusion within the scope of a risk
evaluation for the chemical substance. EPA will also assess what, if
any, additional conditions of use warrant inclusion within the scope of
a risk evaluation for the chemical substance. EPA will conduct these
assessments based on the same considerations applied in the same manner
as it would for a risk evaluation in the EPA-initiated risk evaluation
process.
No later than 60 business days after receiving a manufacturer
request for risk evaluation that EPA has determined to be facially
complete (meeting the criteria set forth in 40 CFR 702.37(e)(1)), EPA
is required to submit for publication the receipt of the request in the
Federal Register, open a public docket for the request (which must
contain the manufacturer request and EPA's possible additional
conditions of use), and provide no less than 45 calendar days for
public comment. This notice identifies the docket containing the
manufacturer request, EPA's possible additional conditions of use, and
the basis for including those possible additional conditions of use.
During the public comment period, the public may submit comments and
information relevant to the requested risk evaluation, as well as the
additional possible conditions of use EPA is including in the docket.
After the comment period closes, the Agency has up to 60 days to
either grant or deny the request to conduct a risk evaluation under 40
CFR 702.37(e)(6). EPA will review the request along with any additional
information received during the comment period, and grant the request
if it determines the request meets all of the following requirements
listed under 40 CFR 702.37(e)(6)(ii):
The circumstances identified in the request constitute
conditions of use that warrant inclusion in a risk evaluation for the
chemical substance;
EPA has all the information needed to conduct such risk
evaluation on the conditions of use that were the subject of the
request; and
All other criteria and requirements of 40 CFR 702.37 have
been met.
C. What action is EPA taking?
EPA is announcing the availability of and soliciting public comment
on a manufacturer request for a risk evaluation of D4 under TSCA
section 6(b) that is described in detail in Unit II. Also available in
the docket associated with this request are the manufacturer request
and possible additional conditions of use EPA identified for inclusion
in a risk evaluation of D4. This notice satisfies 40 CFR 702.37(e)(4).
D. What should I consider as I prepare my comments for EPA?
1. Submitting CBI. Do not submit this information to EPA through
regulations.gov or email. Clearly mark the part or all of the
information that
[[Page 36588]]
you claim to be CBI. For CBI information in a disk or CD-ROM that you
mail to EPA, mark the outside of the disk or CD-ROM as CBI and then
identify electronically within the disk or CD-ROM the specific
information that is claimed CBI. In addition to one complete version of
the comment that includes information claimed as CBI, a copy of the
comment that does not contain the information claimed as CBI must be
submitted for inclusion in the public docket. Information so marked
will not be disclosed except in accordance with procedures set forth in
40 CFR part 2.
2. Tips for preparing your comments. When preparing and submitting
your comments, see the commenting tips at https://www.epa.gov/dockets/comments.html.
II. Summary of This Manufacturer Request
On March 19, 2020, EPA received a complete manufacturer request for
a TSCA risk evaluation of D4 that was made by Dow Silicones
Corporation, Elkem Silicones USA Corporation, Evonik Corporation,
Momentive Performance Materials, Shin-Etsu Silicones of American, Inc.;
and Wacker Chemical Corporation through the American Chemistry
Council's Silicones Environmental, Health, and Safety Center (SEHSC).
After determining the request was facially complete (i.e., EPA
determined that the request appeared to be consistent with the
requirements in 40 CFR 702.37(b) through (d), such as including all the
necessary information in those paragraphs), EPA notified the public of
the receipt of the request on April 8, 2020 via a listserv announcement
to stakeholders.
A. What is octamethylcyclotetra-siloxane (D4)?
D4 is used to make other silicone chemicals and as an ingredient in
some personal care products. This substance is listed on the TSCA
Inventory with CA Index Name ``Cyclotetrasiloxane, 2,2,4,4,6,6,8,8-
octamethyl-'' and the associated Chemical Abstracts Service Registry
Number (CASRN) 556-67-2.
B. What are the conditions of use?
The manufacturer request for a risk evaluation of D4 identifying
conditions of use of interest to the manufacturer is included in docket
EPA-HQ-OPPT-2018-0443. Subject to further analysis and public comment,
EPA anticipates including activities identified in the request as
conditions of use in the risk evaluation of D4.
EPA has identified additional conditions of use pursuant to 40 CFR
702.37(e)(3), which are also included in docket EPA-HQ-OPPT-2018-0443.
III. Request for Comment
The docket associated with this request contains the manufacturer
request (excluding information claimed as CBI), EPA's possible
additional conditions of use as described 40 CFR 702.37(e)(3), and the
basis for these possible additions. During the comment period, the
public may submit comments and information relevant to the requested
risk evaluation; in particular, commenters are encouraged to identify
any information not included in the request that the commenters believe
would be needed to conduct a risk evaluation, and to provide any other
information relevant to EPA's possible additional conditions of use,
such as information on other conditions of use of the chemical
substance than those included in the request or in EPA's possible
additional conditions of use. 40 CFR 702.37(e)(4). In addition, at any
time prior to the end of the comment period, the requesting
manufacturer(s) may supplement the original request with any new
information it receives. 40 CFR 702.37(e)(5).
Authority: 15 U.S.C. 2601 et seq.
Andrew Wheeler,
Administrator.
[FR Doc. 2020-13037 Filed 6-16-20; 8:45 am]
BILLING CODE 6560-50-P
